Equities analysts predict that HB Fuller Co (NYSE:FUL) will report earnings per share of $0.86 for the current quarter, according to Zacks. Four analysts have made estimates for HB Fuller’s earnings. The highest EPS estimate is $0.87 and the lowest is $0.84. HB Fuller posted earnings of $0.62 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 38.7%. The business is expected to issue its next earnings results on Wednesday, June 27th.
According to Zacks, analysts expect that HB Fuller will report full-year earnings of $3.22 per share for the current financial year, with EPS estimates ranging from $3.15 to $3.30. For the next fiscal year, analysts anticipate that the company will post earnings of $4.02 per share, with EPS estimates ranging from $3.75 to $4.22. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover HB Fuller.
HB Fuller (NYSE:FUL) last released its quarterly earnings results on Wednesday, March 28th. The specialty chemicals company reported $0.35 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.01. The company had revenue of $713.08 million for the quarter, compared to the consensus estimate of $663.98 million. HB Fuller had a net margin of 3.62% and a return on equity of 11.69%.
A number of equities research analysts recently issued reports on the stock. Robert W. Baird reaffirmed a “hold” rating and set a $54.00 price target on shares of HB Fuller in a research note on Monday, April 2nd. TheStreet downgraded shares of HB Fuller from a “b” rating to a “c+” rating in a research note on Monday, February 26th. Finally, Zacks Investment Research downgraded shares of HB Fuller from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. One analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $60.50.
In other news, CFO John J. Corkrean acquired 3,200 shares of the business’s stock in a transaction on Monday, April 23rd. The shares were acquired at an average price of $51.99 per share, for a total transaction of $166,368.00. Following the completion of the transaction, the chief financial officer now directly owns 8,247 shares of the company’s stock, valued at approximately $428,761.53. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 3.46% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Koch Industries Inc. bought a new position in HB Fuller during the fourth quarter valued at $205,000. Capital Fund Management S.A. bought a new position in HB Fuller during the fourth quarter valued at $242,000. PEAK6 Investments L.P. bought a new position in HB Fuller during the fourth quarter valued at $243,000. Xact Kapitalforvaltning AB bought a new position in HB Fuller during the fourth quarter valued at $249,000. Finally, Meadow Creek Investment Management LLC increased its position in HB Fuller by 25.1% during the fourth quarter. Meadow Creek Investment Management LLC now owns 6,972 shares of the specialty chemicals company’s stock valued at $376,000 after acquiring an additional 1,400 shares during the last quarter. Institutional investors and hedge funds own 97.68% of the company’s stock.
HB Fuller traded up $0.20, reaching $55.72, during mid-day trading on Friday, Marketbeat Ratings reports. 465,876 shares of the company’s stock traded hands, compared to its average volume of 437,630. The company has a market cap of $2.80 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 1.11 and a beta of 1.54. The company has a quick ratio of 1.35, a current ratio of 2.14 and a debt-to-equity ratio of 2.08. HB Fuller has a 12-month low of $46.62 and a 12-month high of $58.74.
About HB Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.
Get a free copy of the Zacks research report on HB Fuller (FUL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.